Double-blind study of ipratropium bromide, a new anticholinergic bronchodilator.

Abstract

The efficacy and acceptability of ipratropium given by metered-dose inhaler were evaluated in two double-blind crossover tests against placebo, one preceding and one following a 2-wk period of continual open-label ipratropium treatment. Ten patients with chronic bronchitis and 10 with bronchial asthma participated. Ipratropium produced increase in FEV 1 of… (More)

Topics

Cite this paper

@article{Chervinsky1977DoubleblindSO, title={Double-blind study of ipratropium bromide, a new anticholinergic bronchodilator.}, author={Paul S Chervinsky}, journal={The Journal of allergy and clinical immunology}, year={1977}, volume={59 1}, pages={22-30} }